These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15379620)

  • 1. Is there a role for oral anticoagulant therapy in patients with peripheral arterial disease?
    Cosmi B; Palareti G
    Curr Drug Targets Cardiovasc Haematol Disord; 2004 Sep; 4(3):269-73. PubMed ID: 15379620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral anticoagulant therapy in patients with peripheral artery disease.
    Visseren FL; Eikelboom BC
    Semin Vasc Med; 2003 Aug; 3(3):339-44. PubMed ID: 15199468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging drugs in peripheral arterial disease.
    Tulsyan N; Ouriel K; Kashyap VS
    Expert Opin Emerg Drugs; 2006 Mar; 11(1):75-90. PubMed ID: 16503827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infrainguinal bypass surgery.
    Tangelder MJ; Lawson JA; Algra A; Eikelboom BC
    J Vasc Surg; 1999 Oct; 30(4):701-9. PubMed ID: 10514209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases].
    Dörffler-Melly J; Schmidli J; Mahler F
    Ther Umsch; 2003 Jan; 60(1):36-42. PubMed ID: 12638477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins.
    Dagher NN; Modrall JG
    Semin Vasc Surg; 2007 Mar; 20(1):10-4. PubMed ID: 17386359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic therapy for peripheral arterial disease and claudication.
    Hiatt WR
    J Vasc Surg; 2002 Dec; 36(6):1283-91. PubMed ID: 12469066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug treatment of peripheral arterial disease in the elderly.
    Aronow WS
    Drugs Aging; 2006; 23(1):1-12. PubMed ID: 16492065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombosis and antithrombotic agents in peripheral artery disease].
    Emmerich J
    Arch Mal Coeur Vaiss; 2002 Nov; 95 Spec No 7():59-62. PubMed ID: 12500607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials.
    WAVE Investigators
    Am Heart J; 2006 Jan; 151(1):1-9. PubMed ID: 16368284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Clagett GP; Sobel M; Jackson MR; Lip GY; Tangelder M; Verhaeghe R
    Chest; 2004 Sep; 126(3 Suppl):609S-626S. PubMed ID: 15383487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery.
    Dörffler-Melly J; Büller HR; Koopman MM; Prins MH
    Cochrane Database Syst Rev; 2003; (4):CD000536. PubMed ID: 14583924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral arterial occlusive disease: conservative treatment of intermittent claudication.
    Kriessmann A
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S72-4. PubMed ID: 1369724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding increases the risk of ischemic events in patients with peripheral arterial disease.
    van Hattum ES; Algra A; Lawson JA; Eikelboom BC; Moll FL; Tangelder MJ
    Circulation; 2009 Oct; 120(16):1569-76. PubMed ID: 19805650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
    ; Anand S; Yusuf S; Xie C; Pogue J; Eikelboom J; Budaj A; Sussex B; Liu L; Guzman R; Cina C; Crowell R; Keltai M; Gosselin G
    N Engl J Med; 2007 Jul; 357(3):217-27. PubMed ID: 17634457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of surgical and thrombolytic treatment of peripheral arterial disease.
    Ouriel K
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S7-16. PubMed ID: 12556738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of major haemorrhage in patients after infrainguinal venous bypass surgery: therapeutic consequences? The Dutch BOA (Bypass Oral Anticoagulants or Aspirin) Study.
    Ariesen MJ; Tangelder MJ; Lawson JA; Eikelboom BC; Grobbee DE; Algra A;
    Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):154-9. PubMed ID: 15996602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term risk of vascular events after peripheral bypass surgery. A cohort study.
    Van Hattum ES; Tangelder MJ; Lawson JA; Moll FL; Algra A
    Thromb Haemost; 2012 Sep; 108(3):543-53. PubMed ID: 22871801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of antithrombotic agents in peripheral arterial diseases].
    Wütschert R; Bounameaux H
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1551-5. PubMed ID: 9092417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication.
    Cosmi B; Conti E; Coccheri S
    Cochrane Database Syst Rev; 2001; (3):CD001999. PubMed ID: 11687006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.